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Abstract
The major histocompatibility complex (MHC) is one of the most variable and gene-dense regions of the human genome.
Most studies of the MHC, and associated regions, focus on minor variants and HLA typing, many of which have been
demonstrated to be associated with human disease susceptibility and metabolic pathways. However, the detection of
variants in the MHC region, and diagnostic HLA typing, still lacks a coherent, standardized, cost effective and high coverage
protocol of clinical quality and reliability. In this paper, we presented such a method for the accurate detection of minor
variants and HLA types in the human MHC region, using high-throughput, high-coverage sequencing of target regions. A
probe set was designed to template upon the 8 annotated human MHC haplotypes, and to encompass the 5 megabases
(Mb) of the extended MHC region. We deployed our probes upon three, genetically diverse human samples for probe set
evaluation, and sequencing data show that ,97% of the MHC region, and over 99% of the genes in MHC region, are
covered with sufficient depth and good evenness. 98% of genotypes called by this capture sequencing prove consistent
with established HapMap genotypes. We have concurrently developed a one-step pipeline for calling any HLA type
referenced in the IMGT/HLA database from this target capture sequencing data, which shows over 96% typing accuracy
when deployed at 4 digital resolution. This cost-effective and highly accurate approach for variant detection and HLA typing
in the MHC region may lend further insight into immune-mediated diseases studies, and may find clinical utility in
transplantation medicine research. This one-step pipeline is released for general evaluation and use by the scientific
community.
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Introduction
The MHC region, one of the most gene-dense regions of the
human genome, is located on the short arm of human
chromosome 6. It covers over 200 genes, 128 of which are
predicted to be expressed [1]. Most MHC genes play a
fundamental role in immunity, and show a close relationship
with immune-mediated diseases [2,3]. Over 30 years, numerous
studies have demonstrated association between some MHC
alleles and some disease susceptibilities. Today, more than 100
diseases, - with relation to infection, inflammation, autoimmu-
nity, drug sensitivity, and transplantation medicine -have been
reported to be associated with proteins coded by the genes in
MHC region [4].
In addition to its high gene density, the MHC region is also one
of the most complex regions in the human genome, due to the
extremely high density of polymorphism and linkage disequilib-
rium (LD). This inherent complexity has made identification of the
underlying, causative variants contributing to disease phenotypes
by genome-wide association study (GWAS) a challenge. The single
nucleotide variations (SNV) which distinguish PGF and COX, the
two most significant MHC haplotypes in the European popula-
tion, are at variant densities of ,3.46 10–3, higher than the
estimated average heterozygosity between any other two haplo-
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types in the human genome [5]. Recognizing the importance of
fully informative polymorphism and haplotype maps of the MHC
region, as pertaining to MHC-related-diseases, the MHC Haplo-
type Consortium has conducted the MHC Haplotype Project
between 2000 and 2006, and provided the sequence and
annotations of eight different HLA-homozygous-typing haplotypes
(PGF, COX, QBL, APD, DBB, MANN, MCF and SSTO) [6].
The Single Nucleotide Polymorphism (SNP) count in dbSNP for
the MHC region has increased rapidly from 69,076 SNPs in
database version 130 (Apr 30, 2009) to 169,279 in database
version 135 (Oct 13, 2011), due in large part to the progress of the
1000 genome project. Although next generation sequencing (NGS)
has made the cost of human genome sequencing decrease
dramatically, the detection and analysis of all variants in the
human MHC region for a large human cohort by whole genome
sequencing (WGS) is still a challenge for researchers. Particularly
for researchers who focus on genomic variations in MHC region,
and for researchers who use genomic information to do HLA
typing, targeted region sequencing stands out as a promising and
neotypal approach.
The human leukocyte antigen (HLA) genes, the most studied
genes in the MHC region, encode cell-surface proteins responsible
for antigen peptide presentation in adaptive immune response.
Considering the key role of HLA genes in immunology, HLA
typing is widely used for matching donors and recipients in organ
and hematopoietic stem cell transplantation in the clinical context
[7,8], particularly for variants at the four gene loci HLA-A, -B, -C
and -DRB1. High resolution HLA matching is required for
unrelated donor hematopoietic cell transplants [9]. Although
precise HLA matching improves overall transplant survival and
reduces the risk of rejection, graft-versus-host disease (GVHD)
remains a significant and potentially life-threatening complication
after hematopoietic cell transplantation (HCT), even when using
HLA-matched transplants. Besides the five classic HLA genes
(HLA-A, -B, -C, -DRB1 and -DQB1), additional genes in the
MHC region, encoding unidentified transplantation antigens, are
proposed to be responsible for GVHD [10]. Pro¨ll et al. found
3,025 small variations between recipients and donors undergoing
unrelated HLA-matched allogeneic stem cell transplantation, and
proposed that various differences causing non-synonymous amino
acid exchanges may lead to GVHD [11]. Therefore, choosing an
HLA matched unrelated donor with the smallest number of
differences to the recipient may help to reduce risk of rejection and
increase odds of transplantee survival.
Target region capture sequencing was developed mainly to
enrich and sequence specific regions of particular interest, such as
specific exons or entire exomes [12,13]. Target Region Sequenc-
ing (TRS) may be a cost-effective solution for studying MHC
region; however, successful enrichments of large, contiguous,
highly variable genomic regions has previously been thought to be
problematic, because of ubiquitous repetitive regions and other-
wise high diversity between haplotypes. In this study, a probe set
was carefully designed for the target regions, using sequences of
eight MHC haplotypes, to capture DNA fragments from the
human MHC region, and then processed via high throughput
sequencing. Using this probe set, we are able to sequence,97% of
the defined MHC region with high SNV calling accuracy by this
capture sequencing technology. We have also developed a HLA
typing pipeline to type all of the genes in the IMGT/HLA
database (http://www.ebi.ac.uk/imgt/hla,Release 3.9.0) with
high accuracy, using this capture sequencing data or whole
genome sequencing data. This toolset will improve and extend the
usage of both capture sequencing and whole genome sequencing
data in related studies which rely on HLA typing.
Results
Evaluation of Target Capture Sequencing, in Terms of
Coverage
We generate sequence libraries from genomic DNA (gDNA) of
the three samples mentioned in the method. After filtering reads
with low sequence quality or sequencing adaptor, the purged data
are mapped to the human genome reference sequence hg19, and
more than 60% of the mapped reads are proved to align to the
MHC region (Table 1). Although the probes themselves cover only
72.8% of the defined MHC region (3,620,871 bp of
4,970,558 bp), the alignment result proves that 97% of the
defined MHC region is covered by at least one read, and over
95% by at least four reads (Table 1).
Several hundred samples have been captured and sequenced
using this method, and the coverage of the MHC region is over
96% for all samples (data not shown). We investigated the 3–4% of
uncovered regions and found that more than 99% of the
uncovered bases were located in a long repeating region with
length.2000 base per repeat (data not shown), which was difficult
to solve with capture method due to NGS reads typically being too
short to span the breadth of the long repeat region. The MHC
region depth distribution showed a similar Poisson distribution for
all three samples (Figure 1), indicating an even enrichment of the
MHC region.
For further evaluation of the coverage of the genes in the MHC
region, RefSeq genes are downloaded from the UCSC table
browser (Hg19) [14], of which 213 genes and 380 transcripts are
annotated in the defined MHC region. The average coverage of
the longest transcripts of the 213 genes in the MHC region was
99.69% (Table S1). As to the coverage of the exons, the average
coverage of all exons was 99.94% and 210 of 213 genes were
100% covered for all exons for all three samples (Table S1). This
high coverage of the genes in MHC region makes it possible to
detect all variations therein.
Evaluation of Variation Detection Accuracy
Use of the capture sequencing method for mutation discovery is
critically dependent on the accurate detection of polymorphisms
and genotypes. Based on the target capture sequencing data, using
GATK tools (v1.43) for YH, NA18532 and NA18555, respective-
ly, we detected 19,002, 19,007 and 20,022 SNPs, and 2,332,
2,077, and 2,513 insertions and deletions (InDels).
When analyzing the distribution of variations, we found that
most of those SNPs were located in HLA-A, -B, -C, -DR, -DP and
-DQ loci (Figure 2), leading to high degree of polymorphism
within those genes. An average 3% of the SNPs identified in our
study were determined to be novel, defined by their not being
present in dbSNP132, or not being extant in the 1000 Genomes
project (1000 Genomes Project Consortium, http://www.
1000genomes.org, released on 23 November 2010). Using the
ANNOVAR bioinformatics toolset (http://www.
openbioinformatics.org/annovar) to functionally annotate the
genetic variants in MHC region for the three case samples, we
showed that about 2% of all detected variants were within exonic
regions, 16% within intronic regions, and 70% within regions
defined as intergenic (Table S2). Further investigation showed that
most of the nonsynonymous variants resulting in changes to amino
acid sequences - and hence probable functional differences in the
protein - were also located in HLA-A, -B, -C, -DR, -DP and -DQ
genes, putatively resulting in different peptide-binding interactions
with T cell receptors.
In order to evaluate the accuracy of SNP detection, we
compared our genotype result with the Illumina 2.5 M BeadChip
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genotype result for YH, and with HapMap genotype result for
NA18555 and NA18532. There were 6,099 sites on the Illumina
2.5 M BeadChip which are within the MHC region, and 13,920
and 14,036 genotypes in the HapMap database for NA18532 and
NA18555 respectively. 6,066 (99.5%), 13,775 (99.0%) and 13,895
(99.0%) of these genotypes are identified by target capture
sequencing data with an accuracy of 98.83%, 97.82% and
98.26%, respectively, for the three study samples (Table S3, S4
and S5). The rate of divergence (about 2%) of our genotype results
from the HapMap genotypes is calculated to be higher than the
estimated average error rate of HapMap genotypes of 0.5% [15].
Two-thirds of the divergent loci show missing data at one allele in
the HapMap genotype, which indicating that these inconsistent
sites might result from failure of amplification, caused by the high
background heterozygosity of the MHC region. Due to this high
degree of divergence between any given pair of MHC haplotypes,
biased enrichment data may likewise lead to an erroneous result.
In order to evaluate the bias of our reads on two different MHC
haplotypes, we therefore count the support read number for each
allele at the heterozygous locus in the BeadChip for YH, and
HapMap data for NA18532 and NA18555. This count shows that
most of the sites had equal support reads for the non-reference
allele and reference allele, by which we infer that our probes
display good enrichment balance for the two haplotypes (Figure 3).
In order to validate the authenticity of the novel SNPs and
InDels, two already proved fosmids covering the HLA–B gene
locus were generated, based on our previous project using YH
gDNA. Both of the selected fosmids covered the MHC region of
chr6 :31,317,939 – 31,344,876 (hg19), but they each are
templated on different haplotypes. Using the sequence data from
fosmids, we validated the accuracy of 379 of the 382 SNPs
(99.21%) (including 14 of the 15 novel SNPs) and 35 of the 37
InDels (94.59%) (data not shown).
Description of HLA Typing Method
Since the target capture sequencing data can be expected to
cover more than 99% of genes in MHC region, it has the potential
to give all MHC HLA gene types. Here, based on the above cited
TRS data, we have developed an HLA typing pipeline which
enables typing all of the HLA genes in the IMGT/HLA database
until the date of publishing. The pipeline takes the aligned BAM
files as input, and outputs the most reliable HLA types for each
gene (Figure 4).
A brief summary of the pipeline was as follow:
(1) Read preparation: Paired reads with either end mapped
to target gene region, and unmapped paired reads with high
quality, are categorized by gene, and extracted from the BAM. (2)
Quality control and error correction: The collected reads of
each gene are aligned to the IMGT/HLA database, which
contains the sequence of all currently known types, using Basic
Local Alignment Search Tool (BLAST, version 2.2.24). Reads
with a maximum of two discordant (SNP/InDel) to the most
similar reference sequence in the database are kept and corrected
to the closest reference sequence, while maintaining and adding to
a record of the discordant SNP/InDel variants. (3) Haplotype
sequence assemble: For each exon, reads are randomly
assembled, with a minimum overlap region length of 10 bp for
reads with no difference allowed in the overlap region, so as to
construct haplotypes. Artificial haplotypes that do not exist in
IMGT/HLA database are filtered out, and remaining haplotypes
are given quality scores as defined below (see method). (4) Typing
according to assembled haplotype sequence: The final
haplotype of the sample is determined by rank of quality score (See
method).
Figure 1. Distribution of per-base coverage depths in the MHC region for three samples. X-axis denotes coverage depth, Y-axis indicates
percentage of total target region with a given sequencing depth. The fraction of target bases with zero coverage is not shown in the figure.
doi:10.1371/journal.pone.0069388.g001
Table 1. Data production and mapping results for the three
samples used.
Samples YH NA18532 NA18555
Target region ( bp) 4970558 4970558 4970558
Raw reads 7988210 5377408 5457998
Raw data (Mb) 719 484 491
Mapped reads 7766430 4875514 4991960
Uniquely mapped reads 7317777 4559340 4672521
Reads uniquely mapped to target 4794113 3023307 3100770
Capture specificity 65.51% 66.31% 66.36%
Mean fold coverage depth (x) 87.32 55.09 56.50
Percent bases with coverage $1x 97.29 96.95 97.20
Percent bases with coverage $4x 96.52 95.66 95.95
Percent bases with coverage $10x 95.50 93.84 94.13
Target regions here refer to contiguous MHC regions, rather than to the region
actually covered by the designed probes. Capture specificity is defined as the
percentage of uniquely mapped reads aligning to the target region.
doi:10.1371/journal.pone.0069388.t001
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Evaluation of HLA Typing Accuracy
Firstly, we test our HLA typing pipeline on simulated data.
Based on the sequence of eight known haplotypes, sequenced by
Sanger’s MHC haplotype project in 2008 with a foreknown
HLA type result, we simulated regional sequence data for a
diploid sample MHC, and ran the HLA typing pipeline upon it.
For each sample, we typed 26 HLA genes, as recorded in
IMGT/HLA database. The simulated data showed the accuracy
of our method at 2 and 4 digital resolutions, and at sequencing
depths ranging from 206 to 1006 with sequencing error rates
ranging from 0–2% (Table S6). The results of this typing were
then validated against the HLA type given by the MHC
haplotype project.
We then used this pipeline on three real human genome
samples selected for this study. For each sample, we typed the
same 26 HLA genes recorded in the IMGT/HLA database. In
order to estimate the accuracy of the HLA typing result, we typed
the nine HLA genes with the highest diversity in the IMGT/HLA
database using the gold standard: Polymerase Chain Reaction
(PCR) based Sanger sequencing, at 4 digital resolution. When our
pipeline was compared with this standard, 100% of the 54 HLA
alleles typed by our method were found consistent with those of
the Sanger standard at 4 digital resolution (Table S7).
In a second test project, 190 human samples which had already
been typed by traditional SSO or PCR based Sanger sequencing
method (the same gold standard) were captured and sequenced
using our pipeline, comparing in particular on five genes (HLA-A,
-B, -C, -DRB1 and -DQB1). The comparison showed that the
concordance of our method with the traditional gold standard was
96.4% at 4 digital resolution, and 98.8% at 2 digital resolution
(data not shown). This result indicates the high performance and
reliability of our targeted region pipeline.
Discussion
In our study, we have developed an efficient approach for
targeted region sequencing of the MHC region of the human
genome, focusing on detection of minor variants and HLA types,
in a high-coverage, high-reliability and low-cost framework.
Beyond the 3.4 Mb of the standard MHC region, we designed
probes for a continuous 5 Mb genomic region, to include further
information from the extended high linkage disequilibrium area of
the broader MHC region.
Our data presents 97% coverage for the broader MHC region
and 99.69% for the transcripts of the crucial MHC genes, in all
three testing samples. Compared with the method of Proll [11],
our study showed a significantly higher coverage of the MHC
region. Moreover, the accuracy of SNVs identified by our target
capture sequencing data was in particularly high concordance with
genotype data established by the most reliable methodology for
this purpose, indicating the high degree of reliability of our
approach.
To overcome the challenge of accurately genotyping the
extremely high density of polymorphisms and linkage disequilibria
in the human MHC region, our method optimized the standard
target capture sequencing pipeline. Unlike traditional probes,
which are designed only based on one of the haplotypes of the
human reference sequence, the probe design for the MHC region
in this study is based on all eight major MHC haplotype
sequences. This enables capture of less common haplotypes in
this region, ultimately reducing capture bias and failure. We also
Figure 2. Single nucleotide variation distribution across the whole MHC region for three samples. The MHC region was split into 4971
parts, with 1000 bp in each part. X-axis denotes the 4971 parts and Y-axis indicates the number of SNPs in each part.
doi:10.1371/journal.pone.0069388.g002
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shear DNA fragments to ,500 bp, increasing the coverage of the
MHC region compared to the shorter fragments length around
,200 bp (Table S8) which is more typically used in conventional
exon capture libraries. This is particularly useful in the MHC
because probes must be annealed to unique regions, but some
repetitive regions, which are not covered by the probes, can be
enriched by flanking to unique genome regions close to them, by
using a longer and more unique genome fragment.
Based on this high-coverage, low-bias capture data, we achieve
exceptionally accurate SNP and InDel results, and exceptionally
accurate HLA gene type results in MHC region, at a level which
before could only be achieved by a more specialized and expensive
experimental method, or based on a large database. The
traditionally utilized HLA typing methods - such as sequence
specific oligonucleotide (SSO), sequence specific primer (SSP) [16],
PCR based capillary sequencing and next generation sequencing
method [17] - only detect variants in two or three exons, and it is
very possible for new alleles in other regions of the gene to be
missed when using these traditional methods. Another forwar-
dlooking method has been reported for the imputation classical
HLA alleles and corresponding amino acid based on the SNP
information in the MHC region [18], but it demands a huge well
studied reference panel. Our data covers essentially all regions of
known HLA genes, and has the potential for more accuracy and
higher resolution in typing, as well the potential for the detection
of novel types (a not infrequent occurrence in this highly
polymorphic region), and an important clinical clue in the event
of tissue rejection and GVHD. High coverage data allows us to
detect all variants and type all HLA genes in the MHC region in
one-step with low cost. Some researchers suggest that the
transplant barrier is defined not only by classical HLA genes,
but also by non-HLA genetic variation within the MHC [10], but
many previously dominant methods have been unable to gather
data of sufficient breadth to verify or refute this contention.
One limitation of our target region method, as well as most
other methods, is the inability to fully cover long repeated regions,
and present 100% coverage of MHC region. This difficulty may
later be overcome by shearing gDNA to longer fragments
(5000 bp, or longer), capturing using probes of this size, and
sequencing on the third generation sequencing platforms. A
solution to this difficulty is important and may open the possibility
of phasing long MHC haplotype blocks at low cost, ultimately
reducing the risk of transplantation rejection and GVHD for those
less able to afford a more expensive solution.
Conclusion
The MHC region harbors the highest density of immunity-
crucial genes in the human genome, and is arguably the region
Figure 3. Capture bias evaluation using heterozygous genotypes in the Beadchip for three samples. X-axis denotes the support reads
number of the reference allele and Y-axis denotes the support reads number of the non-reference allele.
doi:10.1371/journal.pone.0069388.g003
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most central to immunogenetics and tissue transplantation. The
ability to accurately call variants and HLA types is very important
to immunology related studies in general, and to clinical
application in particular. In this paper, we outline our develop-
ment of a novel, low cost pipeline for the identification of variants
and typing of HLA alleles in the MHC region in a one step
protocol with high accuracy. This pipeline has great potential for
use in the study of immune disease and transplantation medicine.
Materials and Methods
Design of MHC Capture Probes
The classical MHC region is defined as a ,3.4 Mb region
stretching between the gene C6orf40 (ZFP57) and the gene
HCG24 [19]. In this study, due to extreme linkage disequilibrium
of the region, and due to the presence of MHC-relevant genes
nearby [19], we extended the MHC region to the telomeric gene
GPX5 and the centromeric gene ZBTB9 in the probes design,
corresponding to the genomic region from chr6:28,477,797 to
chr6:33,448,354 in the human reference genome (NCBI release
GRCh37, UCSC release hg19), encompassing a total of
4,970,558 bp.
Unlike previous studies of the MHC region, we also include the
other seven MHC haplotypes aside from PGF - namely COX,
QBL, APD, DBB, MANN, MCF and SSTO - in our probes
design so as to improve the coverage of the MHC region and
minimize the effect of the regionally high polymorphism density. A
maximum allowance of greater than 5 close matches is set to get
optimal capture efficiency of such high polymorphic regions. In
total, 3,620,871 bp (about 72.8% of the 5 Mb MHC region) was
covered by the capture probes for PGF, and the coverage rose to
4150331 bp (83.5%) when probes extended by 100 bp at both
end. The design name is 110729_HG19_MHC_L2R_D03_EZ
and design file can be downloaded from Roche NimbleGen
website (http://www.nimblegen.com/products/seqcap/ez/
designs/index.html) in the product ‘‘human MHC design’’. Five
Figure 4. The workflow of HLA typing method.
doi:10.1371/journal.pone.0069388.g004
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capture arrays were initially produced for testing the uniformity of
coverage, and the regions with extremely low or high sequencing
depth were rebalanced by adjusting the number of probes - probe
count for regions with extremely low sequencing depth was
increased, and for regions with extremely high sequencing depth
was decreased. Target region sequencing of the MHC was
conducted for three samples using the set of rebalanced probes.
Samples Collection
Three samples were used to evaluate the performance of the
MHC region capture strategy. One was YH, which had previously
been whole genome deep sequenced in 2008 [20], and genotyped
using Illumina 2.5 M BeadChip. The other two samples were cell
line DNA, NA18532 and NA18555, which were purchased from
Coriell Institute, and which had previously been analyzed using
high-throughput SNP genotyping in the HapMap project [21].
Nine HLA allele (HLA-A, HLA–B, HLA–C, HLA-DRB1,
HLA-DQB1, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-G)
types for these samples were already detected using the gold
standard sequence based typing method, in which the exonic
regions of HLA genes were initially amplified by PCR, and the
amplicons were subsequently sequenced using Sanger method.
Whole Genome Shotgun Library Construction
High molecular weight gDNA was extracted using DNeasy
Blood & Tissue Kits (QIAGEN, 69581). Shotgun libraries were
generated from 3 micrograms ( mg) of genomic DNA followed by
the manufacturer’s instruments (Illumina). gDNA in Tris-EDTA
was sheared into 400–600 bp fragments using a Covaris S2
(Covaris). The overhangs were then converted to blunt ends, using
T4 Polynucleotide Kinase, T4 DNA polymerase and Klenow
polymerase. The fragments were then A-tailed using Klenow (39–
59 exo-). Next, Illumina sequencing adapters with a single ‘‘T’ base
overhang were linked to the A-tailed sample using T4 DNA
Ligase. Finally, the fragments with adapters were enriched via four
cycles of PCR.
MHC Region Capture and High Throughput Sequencing
One mg of prepared sample library was hybridized to the
capture probes following the manufacturer’s protocols (Roche
NimbleGen). The hybridization mixture was incubated for 70 h at
65uC. After the hybridization was finished, the target fragments
were captured with M-280 Streptavidin Dynabeads (Invitrogen),
and then the captured sample was washed twice at 47uC and three
more times at room temperature using the manufacturer’s buffers.
The captured target fragments were amplified using PlatinumH
Pfx DNA Polymerase (Invitrogen) at the following condition: 94uC
for 2 min, followed by 15 cycles of 94uC for 15 s, 58uC for 30 s,
72uC for 50 s and a final extension of 72uC for 5 min. The PCR
products were purified and sequenced with standard 26 91
paired-end reads on the Illumina HiSeq2000 sequencer following
manufacturer’s instructions.
Sequencing Read Mapping and Variant Calling
Low quality and adapter contaminated reads were filtered out
to get the clean reads and then they were aligned to the reference
assembly (UCSC Hg19) with haplotypes sequence removed using
Burrows-Wheeler Aligner (BWA, version 0.5.9) with the param-
eters -o 1 -e 63 -i 15 -L -k 2 -l 31 -q 10–I [22]. PCR duplicates
were removed by Samtools (version 0.1.17) [23]. Base qualities
were recalibrated and reads were realigned around potential
insertions and/or deletions using The Genome AnalysisToolkit
(GATK) software (version 1.43). SNPs and InDel were also
detected using GATK for the regions with at least 46 sequencing
depth as described previously [24,25].
HLA Genes Haplotype Sequences Assemble
As showed in Figure 4, De novo assembling method was used to
construct the haploid sequence for each exon by using overlapped
reads. The assembled sequence was randomly paired if the whole
exon was broken by low depth region. We filtered those sequences
that did not exist in the IMGT/HLA database. As for the
remaining haplotype sequences, we scored them according to the
following formula:
Score~C2|N= log (R)
C: Coverage of this assembled sequence to its corresponding
exon;
N: Number of reads used to construct the assembled sequence;
R: Reliability of this assembled sequence. It was calculated using
the following formula:
R~
P
Xi{Xð Þ27X
h i
log dfð Þ :
Xi: The depth of each base of the assembled sequence;
X: The mean depth of the assembled sequence;
df: The degrees of freedom of the assembled sequence.
df =N21, N equals the length of assembled sequence.
Typing According to Assembled Haplotype Sequence
We combined the assembled sequences (called haplotypes) of all
exons together to produce a group of types, and then scored them
using the following formula:
TScore~N|S
N: The number of reads that support the haplotype.
S: The score of the haplotype.
Based on the assumption that number of reads mapped to the
correct haplotype is larger than that mapped to the incorrect
haplotype, we first select the two types with the highest TScore,
which can explain the highest number of the sequence reads for all
exons as candidate types, and then we divide the sequence reads
into two corresponding groups. We judge whether a HLA gene
would be a homozygous or heterozygous, depending on the ratio
of unique supporting reads number of the sub-optimal type,
compared to the supporting reads number of the best type. The
threshold of a heterozygote is 0.1. If the ratio is smaller then 0.1,
the gene is defined as a homozygote, and the type with the largest
score is chosen as the dominant type. Otherwise, the typed gene is
defined as heterozygote, and the two types with the highest score
are chosen as the final type result. Finally, we assess the reliability
of the final type by comparing it with the closed type using AScore:
AScore~
S0{S1ð Þ2
S0{S1ð Þ2z S0{S2ð Þ2
An Integrated Tool to Study MHC Region
PLOS ONE | www.plosone.org 7 July 2013 | Volume 8 | Issue 7 | e69388
S0: The full score of the all assembled haplotypes of the typed
gene;
S1: The score of the closed type;
S2: The score of the final type.
On the other hand, all the discordant information recorded in
the process of ‘error correction’ was judged using variant calling
methods to check whether there is a novel SNP or InDel
comparing to an extant type. If so, the relationship of the novel
variant to the given type was also described.
Data Simulation and HLA Typing
Basing on the sequence of eight MHC haplotypes given by the
MHC haplotype project in 2008, we randomly simulated one
diploid sample’s MHC region sequence data using wgsim (v 0.2.3)
provided by the Samtools package. First, we randomly selected
two from the eight haploids, at various sequencing depths and
various sequencing error rates using parameters –e and –N. The
insertion size was set to 500 bp, which was the same as our target
capture sequencing data, and the SD was 10. For each of the given
conditions, we simulated 36 human MHC region data sets. We
then worked out each simulated sample’s 26 HLA gene’s type
result, using the method we describe above. The statistical
accuracy result is given in Table S6.
Data Access
The raw target capture sequencing data of MHC region for
sample YH, NA18526 and NA18555 has been deposited at the
NCBI Sequence Read Archive (SRA) under accession no.
SRA065846. The HLA typing pipeline is implemented in Perl
script and can be freely downloaded at http://soap.genomics.org.
cn/SOAP-HLA.html.
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